Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.000
-0.460 (-13.29%)
At close: Dec 20, 2024, 4:00 PM
2.940
-0.060 (-2.00%)
After-hours: Dec 20, 2024, 7:58 PM EST
Quantum BioPharma Employees
Quantum BioPharma had 17 employees as of December 31, 2022. The number of employees increased by 7 or 70.00% compared to the previous year.
Employees
17
Change (1Y)
7
Growth (1Y)
70.00%
Revenue / Employee
n/a
Profits / Employee
-$602,175
Market Cap
5.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 17 | 7 | 70.00% |
| Dec 31, 2021 | 10 | 1 | 11.11% |
| Dec 31, 2020 | 9 | -9 | -50.00% |
| Dec 31, 2019 | 18 | -1 | -5.26% |
| Dec 31, 2018 | 19 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| T2 Biosystems | 113 |
| PAVmed | 107 |
| Kindly MD | 65 |
| Vincerx Pharma | 42 |
| Addex Therapeutics | 23 |
| Alzamend Neuro | 7 |
| Adial Pharmaceuticals | 7 |
| Portage Biotech | 7 |
QNTM News
- 14 hours ago - Quantum Biopharma Announces Closing of Second Tranche - Accesswire
- 1 day ago - Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency - Accesswire
- 1 day ago - Quantum BioPharma Diversifies Treasury with the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency - GlobeNewsWire
- 7 days ago - Quantum Biopharma Announces Closing of First Tranche - Accesswire
- 11 days ago - Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) - Accesswire
- 16 days ago - Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million - Accesswire
- 26 days ago - Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation - Accesswire
- 7 weeks ago - Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia - Accesswire